A Płaźnik, E Tamborska, M Hauptmann, A Bidziński, W Kostowski
Index: Brain Res. 447(1) , 122-32, (1988)
Full Text: HTML
The effect of inescapable footshock (IS) upon rats' motor activity (the open field and forced swim tests) was studied in rats subjected to drugs, and neurotoxin treatments, affecting their central neurotransmitter systems. The agonists of GABA-receptor complex, dopamine, noradrenaline and serotonin neuronal systems, as well as the cholinergic antagonist, partially reversed motor suppression induced by IS, while the dopamine agonist, chlorpromazine, and the cholinergic antagonist, physostigmine, potentiated it. The effects of chemical lesions of the brain monoaminergic neurons with p-chlorophenylalanine (pCPA), N-chloro-ethyl-2,2-bromo-benzylamine (DSP-4), 6-hydroxydopamine (6-OHDA) and 5,7-dihydroxytryptamine (5,7-DHT) were more complex, depending upon the extent of monoamine depletion, and the kind of test applied. It is concluded that a decrease in the brain noradrenergic, serotonergic, dopaminergic and GABAergic neuronal activity, as well as the central cholinergic hyperactivity, might contribute to the behavioral suppression after IS. Thus the central mechanisms of behavioral deficits produced by IS involve multiple neurotransmitter systems, and the analysis of their role in more complicated behavioral patterns must also take into account changes in animals' baseline and stimulated motor activity.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Physostigmine salicylate
CAS:57-64-7 |
C22H27N3O5 |
|
Possible interaction of cholinergic and GABAergic systems be...
2012-12-01 [Behav. Brain Res. 235(2) , 231-43, (2012)] |
|
The effects of physostigmine infusion on patients with panic...
1991-04-01 [Biol. Psychiatry 29(7) , 658-64, (1991)] |
|
Development and optimization of a sublingual tablet formulat...
2009-09-01 [Acta. Pharm. 59(3) , 301-12, (2009)] |
|
Liquid chromatographic analysis of physostigmine salicylate ...
1999-01-01 [J. Pharm. Biomed. Anal. 18(6) , 939-45, (1999)] |
|
Toxicity study of continuous administration of physostigmine...
1988-11-01 [Pharmacol. Biochem. Behav. 31(3) , 627-31, (1988)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
